JP Morgan Maintains Neutral on HCA Healthcare, Lowers Price Target to $265
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Samik Chatterjee has maintained a Neutral rating on HCA Healthcare (NYSE:HCA) but has reduced the price target from $313 to $265.
November 17, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
JP Morgan has maintained a Neutral rating on HCA Healthcare and lowered the price target from $313 to $265, indicating a potential downside compared to the previous target.
The reduction in price target by a major analyst like JP Morgan suggests a less optimistic outlook on HCA Healthcare's stock performance in the short term. This could lead to negative investor sentiment and a potential decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100